Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 08/20/2025 6:04:49 AM
Board Marks: 278
Posts Today: 0
Board Views Today: 2248
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
28137
Absolutely another intended effect. Whether it
someconcerns
10/10/2016 9:38:32 AM
28136
BIG NEWS in my opinion. This was with 50mg doses
Ultimate
10/10/2016 9:35:36 AM
28135
Think it speeds up also the process of people
(1)
NotRichYet2
10/10/2016 9:33:41 AM
28134
Franchise definition: "the right or license
(3)
Ultimate
10/10/2016 9:32:50 AM
28133
I'm sure that publicizing these prelim results
someconcerns
10/10/2016 9:15:42 AM
28132
It's a proof of concept. You always start small,
Drano
10/10/2016 9:12:14 AM
28131
Goes without saying we wish they had a lot more
(1)
NotRichYet2
10/10/2016 9:06:38 AM
28130
Since it should be preserved and may be deleted
(5)
someconcerns
10/10/2016 9:02:58 AM
28129
It's great that " 2 of 4 patients achieved full
(2)
Drano
10/10/2016 8:54:34 AM
28128
Awesome news! Take that shorts!!! Go
(1)
AlanC
10/10/2016 8:33:36 AM
28127
Update: Cellceutix Phase 2 Trial Initial Data
(3)
daydreaming2
10/10/2016 8:05:52 AM
28126
https://www.sciencedaily.com/releases/2016/03/160
(2)
rosalieone
10/10/2016 4:04:02 AM
28125
I would like to think that at least most
someconcerns
10/09/2016 6:35:26 PM
28124
I read about weight loss.
grotty
10/09/2016 6:19:56 PM
28123
In a fast food society like ours . depending on
NotRichYet2
10/09/2016 5:54:33 PM
28122
I recall an article declaring a possible link
Dynabolic
10/09/2016 5:45:20 PM
28121
I read about weight loss.
grotty
10/09/2016 5:41:07 PM
28120
Question on KEVETRIN . I know and have seen
NotRichYet2
10/09/2016 4:50:14 PM
28119
Would think investors in OTHER BIO stocks who are
(1)
NotRichYet2
10/09/2016 4:41:38 PM
28118
I think they pasted some new opening paragraphs
Drano
10/09/2016 3:36:28 PM
28117
Exactly, and it would also be utterly unethical.
Drano
10/09/2016 3:35:51 PM
28116
Nothing new in this article
grotty
10/09/2016 1:25:40 PM
28115
Who would subject themselves to a trial with the
grotty
10/09/2016 1:16:00 PM
28114
Why the BS about needing control groups in cancer
(1)
Drano
10/09/2016 12:18:03 PM
28113
Yes I'm familiar with the patent process as I too
Kelt
10/09/2016 11:08:58 AM
28112
I'm not saying they didn't have costs.I am saying
Kelt
10/09/2016 10:56:38 AM
28111
No, CTIX did have significant costs -- typically
(3)
Drano
10/09/2016 10:29:23 AM
28110
In Re: ; (3) the significant costs incurred by
(3)
Kelt
10/09/2016 10:12:43 AM
28108
I think we'll get an update on the first cohort
(1)
sox0407
10/08/2016 8:36:59 PM
28107
LR read your post and all the replies. I'm 100%
sox0407
10/08/2016 7:06:09 PM
28106
Well, I finally had the chance to sit and read
(8)
someconcerns
10/08/2016 5:50:51 PM
28104
I think we're going to have to start referring to
Drano
10/08/2016 3:58:18 PM
28103
The Muppets are not going to like that
incubus
10/08/2016 3:50:52 PM
28102
I 'second' that definition.
incubus
10/08/2016 3:48:44 PM
28101
That is why I like seeing comparisons of PRURISOL
(1)
NotRichYet2
10/08/2016 1:39:04 PM
28100
The points brought up were the company steps. NOW
(1)
NotRichYet2
10/08/2016 1:34:49 PM
28099
Much excitement about an injected eczema drug
Drano
10/08/2016 1:15:44 PM
28098
Yes. Many steps in between
grotty
10/08/2016 1:05:33 PM
28097
Believe you left out the eventual stock uplisting
(1)
NotRichYet2
10/08/2016 12:44:07 PM
28096
Anyone interested in AVXL, I posted part of an
Drano
10/08/2016 12:25:44 PM
28095
Believe Dr. B was talking about partnerships
(1)
incubus
10/08/2016 12:24:11 PM
28094
I ran across a term that is the correct one for
Drano
10/08/2016 12:08:23 PM
28093
I thought the market was open Monday but trades
Drano
10/08/2016 11:25:39 AM
28092
Forgot. GO CTIX!
grotty
10/08/2016 11:24:45 AM
28091
Everyone be has a different definition of
(3)
grotty
10/08/2016 11:23:22 AM
28090
From Sullivan filing: "The reasonable
(2)
incubus
10/08/2016 11:21:59 AM
28089
On a brighter note,obviously Sullivan/Ashcroft
(6)
Kelt
10/08/2016 10:16:47 AM
28088
Hopefully Sullivan/Ashcroft has enough
AlanC
10/08/2016 10:10:05 AM
28087
I agree that Sullivan/Ashcroft needs to be on
(2)
AlanC
10/08/2016 10:06:07 AM
28086
I noticed that as well... "This part seems new.
(1)
thefamilyman
10/08/2016 10:03:48 AM
Newer
Older
Recent Articles
BioArctic's Leqembi Gains Approval for Early Alzheimer's Therapy
PowerBank Strengthens AI Integration with Intellistake Partnership
Exciting Presale Milestone Achieved by Lyno AI Investors
CARBIOS Reports Robust Half-Year Results Amid Plant Updates
BioArctic's Innovative Alzheimer Treatment Secures Approval
Market Valuation Signals: Are We Looking at a Bubble?
Kesimpta Shows Promising Results for MS Patients Switching Therapies
Roche Advances MS Research with OCREVUS and Fenebrutinib Insights
ARGAN Secures 'BBB-' Rating From S&P with Stable Outlook
Atos' Groundbreaking Cybersecurity Partnership with European Commission
Kesimpta: New Study Results Highlight Efficacy in MS Treatment
Burning Rock Receives Japanese Approval for New Cancer Diagnostic
Senator Warren Calls for Investigation on TV Giants' Deals
Elisa's Innovative Call Blocking Feature Disrupts Phone Scammers
Artea Bankas Secures ECB Approval for Stock Buyback Initiative
Totalkredit A/S Releases Comprehensive Debtor Distribution Data
Essential Data on Nykredit Realkredit A/S Mortgage Bonds
Implantica's RefluxStop Device Receives Favorable FDA Feedback
Celebrating Talent and Culture at the Watermelon Festival
DNO ASA Welcomes New CFO Birgitte Wendelbo Johansen
Foresight Group Expands Share Buyback Program, Enhances Investments
Key Changes at Volta Finance: Retirement of Director
Volta Finance Limited Announces New Dividend for Shareholders
KBC Group's Insights for Bondholders of KBC IFIMA
Volta Finance Limited Sees Leadership Transition Ahead
Youxin Technology Soars After Major Acquisition Announcement
Strengthening Resilience: Corero and Netceed's Partnership
Com Laude Acquires Markmonitor to Create Domain Powerhouse
RF Plasma Generator Market Set for Significant Growth Ahead
OSE Immunotherapeutics Addresses Recent Voting Rights Correction
OSB Group PLC Expands Share Buyback Initiative for Growth
Details of NB Private Equity Partners' Recent Share Buyback
Akropolis Group Secures Stable BB+ Credit Rating Amid Growth Plans
Pollo AI Unveils Revolutionary AI Video Generator for Creators
Chery's LEPAS Revolutionizes Global Mobility with User Summit
Transforming Xinjiang: A Story of Progress and Resilience
Understanding Sampo plc’s Recent Share Buyback Achievements
FLSmidth Expands Share Buy-Back Program With Recent Transactions
Sanofi Releases Q3 2025 Aide Mémoire for Investors
GCCL and Frontage Laboratories Join Forces for Clinical Trials
Gavin Newsom's Strong Stance on Electric Vehicles and GM
Strategic Partnership Enhances Clinical Research Capacity Globally
Sanofi Ventures Expands Commitment by $625 Million to Innovate Healthcare
Micron Technology's Upcoming Memory Innovations and Market Growth
Sanofi Publishes Q3 2025 Financial Update and Resources
AFL Group Reports Solid Financial Growth for 2025 Half-Year
Collaboration Between Lantheus and GE HealthCare for PYLARIFY
Sanofi Ventures Boosts Capital Commitment for Innovative Biotech
Acer Integrates Himax's Innovative AI Sensing in New Notebook
Jasper Therapeutics Faces Class Action Amid Development Challenges